DuPont misses revenue expectations

The company was particularly hurt by weakness and uncertainty in Europe.

By Benzinga Jul 24, 2012 5:58PM
By Viktor Puskorius

DuPont (DD) shares fell 2% Tuesday to close at $47.74 after the company beat Wall Street expectations on profit but missed on revenue. DuPont also revised its full-year outlook.


The company reported a profit of $1.18 billion, or $1.25 a share, a 3% decrease from a year earlier. On an adjusted basis, profit of $1.48 per share beat analyst estimates of $1.46 a share. Sales rose 7% to $11 billion, missing the average analyst estimate of $11.25 billion.


The company's weaker earnings could be attributed to a decrease in volume in its performance chemicals, electronics, and safety product segments. The company also saw decreased volume in Europe, the Middle East, Africa and the Asia-Pacific.


The company was particularly hurt by weakness and uncertainty in Europe. Net sales in Europe, Middle East and Africa were $2.5 billion, a 2% decrease from the first quarter of 2012.


On a positive note, the agriculture segment accounted for a 15% increase in sales and 16% higher pre-tax operating income in the first half of 2012. These outcomes were a result of strong Northern hemisphere business performance for seed and crop production lines.


It will be interesting to see if DuPont's agricultural segment is affected by the drought that has struck the U.S. this summer. Agriculture sales accounted for $3 billion of the company's total sales of $11 billion.


DuPont CEO Ellen Kullman said the company's agriculture, food and bioscience businesses performed well globally, and its advanced materials businesses achieved solid results despite slower growth in some key markets and continued weakness in Europe.


DuPont reaffirmed its outlook for full-year earnings in the range of $4.20 to $4.40 a share, but said it expects to be at the lower end of this range. It attributed those weaker expectations to the global economy, currency issues and a high tax rate. DuPont seems to be taking a more cautious approach for the second half of 2012.


More from Benzinga

0Comments

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

125
125 rated 1
272
272 rated 2
423
423 rated 3
589
589 rated 4
696
696 rated 5
589
589 rated 6
665
665 rated 7
434
434 rated 8
261
261 rated 9
144
144 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
ABTAbbott Laboratories10
AIGAmerican International Group Inc10
AMTDTD Ameritrade Holding Corp10
ATVIActivision Blizzard Inc10
CACA Inc10
More
Fidelity Brokerage Services, Member NYSE, SIPC. (c) 2011 FMR LLC. All rights reserved

VIDEO ON MSN MONEY

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.